|
Patient no. | Reference/year | Age/sex | Comorbidity | Medical devices present | Clinical syndrome | Antibiotic | Outcome |
|
1 | Hsueh et al., 1996 [2, 6] | 1 mo/M | Burns | Ventilator | Ventilator-associated pneumonia | Ciprofloxacin, cefoxitin, amikacin | Died (ARDS) |
|
2 | Hsueh et al., 1996 [2, 6] | 5 mo/F | Neuroblastoma, chemotherapy | Hickman catheter | Bacteremia | Not stated | Recovery without removal of catheter (after 3 days) |
|
3 | Hsueh et al., 1996 [2, 6] | 1 mo/F | Hepatoblastoma, chemotherapy | Port-A-catheter | Bacteremia | Not stated | Recovery without removal of catheter (after 3 days) |
|
4 | Cascio et al., 2005 [13]
| 2 y/M | Type 1 diabetes mellitus | Peripheral catheter | Bacteremia | Ceftriaxone, 10 days | Recovery with removal of catheter (afebrile after 2 days) |
|
5 | Al-Tatari et al., 2007 [14]
| 13 y/M | Congenital hydrocephalus | Lumboperitoneal shunt | Lumboperitoneal shunt infection | TMP-SMX and rifampin (for 14 d after shunt removal) | Recovery 24 h after shunt removal |
|
6 | Bayraktar et al., 2007 [15]
| 5 mo/M | Down syndrome, operation for atrial septal defect and diaphragmatic hernia | Mechanical ventilation | Bacteremia | Vancomycin and ofloxacin | Died |
|
7 | Douvoyiannis et al., 2010 [16]
| 33 d/F | None | None | Bacteremia | Cefepime, 10 days | Recovery (afebrile after a day) |
|
8 | Ceylan et al., 2011 [17]
| 2 mo/M | Hydrocephaly | External shunt | Meningitis sepsis | Ampicillin sulbactam and levofloxacin | Died (cardiopulmonary arrest) |
|
9 | Calderón et al., 2011 [8] | 20 d/M | Congenital heart disease | Mechanical ventilation | Ventilator-associated pneumonia | Piperacillin-tazobactam (14 days) | Recovery |
|
10 | Kodama et al., 2013 [18]
| 3 y/F | Acute myeloid leukemia unrelated cord blood stem cell transplantation | Central venous catheter | Catheter-related bloodstream infection | Ciprofloxacin and minocycline | Recovery with removal of catheter |
|
11 | Ozcan et al., 2013 [19]
| 6 mo/M | Congenital hydrocephalus, prematurity | Ventriculoperitoneal shunt | Meningitis | TMP-SMX and cefoperazone-sulbactam (14 days) | Recovery with removal of shunt |
|
12 | Hendaus et al., 2013 [20]
| 8 d/F | None | None | Meningitis | Cefepime (21 days) | Recovery (afebrile after 2 days) |
|
13 | Eshwara et al., 2014 [10] | 6 d/F | Small for gestational age | None | Meningitis sepsis | TMP-SMX (2 weeks) and ciprofloxacin (6 weeks) | Recovery |
|
14 | Olbrich et al., 2014 [21]
| 11 mo/M | Holoprosencephaly, suboptimal hygienic conditions | Ventriculoperitoneal shunt | Meningitis | TMP-SMX and ceftazidime (21 days) | Recovery (afebrile in 24 h) with complete removal of the cerebrospinal shunt system |
|
15 | This study, 2014 | 3 mo/F | Congenital heart disease | Central venous catheter | Bacteremia | TMP-SMX (21 days) | Recovery (afebrile after 2 days) |
|